白细胞介素-1β激活肾脏基质细胞中MYC依赖的代谢转换,促进肾小管间质纤维化进展
研究通过CKD患者纤维化肾脏的RNA测序发现线粒体与氧化磷酸化基因表达缺失、糖酵解相关酶增加的代谢特征,并在小鼠肾损伤模型、人肾脏基质细胞和类器官中验证IL-1β通过MYC依赖的糖酵解驱动基质细胞增殖与基质产生,抑制IRAK4或MYC可减轻纤维化与肾小管损伤。
要点
- IL-1β刺激人肾脏基质细胞和类器官可诱导MYC依赖的糖酵解,驱动增殖和基质生成。
- MYC与p62直接相互作用,IL-1β通过自噬降解p62导致MYC累积。
- 体内抑制IRAK4或MYC可减轻纤维化和肾小管损伤。
核心结论
- IL-1β与纤维化起始和进展中的代谢转换相关,IL-1β和MYC是肾小管间质疾病的潜在治疗靶点。
研究设计与样本
- 对CKD患者纤维化肾脏进行RNA测序,并在小鼠肾损伤模型、人肾脏基质细胞及人肾脏类器官中进行体内外验证。
主要发现
- 小鼠肾损伤后早期驻留基质细胞中MYC及其靶基因激活,提示急性先天免疫信号调控该转录转换。
- IL-1β刺激人肾脏基质细胞和类器官可重现体内分子事件,诱导MYC依赖的糖酵解,后者为驱动增殖和基质产生所必需。
- MYC与p62直接相互作用,调节p62表达对MYC表达产生相反效应,IL-1β刺激自噬流导致p62降解和MYC累积。
- 体内抑制IRAK4或抑制MYC(体内及人肾脏类器官体外)可消除纤维化并减少肾小管损伤。
关键数值与推荐
- CKD患者纤维化肾脏RNA测序显示线粒体和氧化磷酸化基因表达缺失,同时糖酵解调节因子和酶增加,分别受PGC1α和MYC转录因子控制。
临床怎么用
- 靶向IL-1β信号或MYC可能成为延缓肾小管间质纤维化进展的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Kidney injury is characterized by persisting inflammation and fibrosis, yet mechanisms by which inflammatory signals drive fibrogenesis remain poorly defined.Methods RNA sequencing of fibrotic kidneys from patients with CKD identified a metabolic gene signature comprising loss of mitochondrial and oxidative phosphorylation gene expression with a concomitant increase in regulators and enzymes of glycolysis under the control of PGC1α and MYC transcription factors, respectively. We modeled this metabolic switch in vivo, in experimental murine models of kidney injury, and in vitro in human kidney stromal cells (SCs) and human kidney organoids.Results In mice, MYC and the target genes thereof became activated in resident SCs early after kidney injury, suggesting that acute innate immune signals regulate this transcriptional switch. In vitro, stimulation of purified human kidney SCs and human kidney organoids with IL-1β recapitulated the molecular events observed in vivo, inducing functional metabolic derangement characterized by increased MYC-dependent glycolysis, the latter proving necessary to drive proliferation and matrix production. MYC interacted directly with sequestosome 1/p62, which is involved in proteasomal degradation, and modulation of p62 expression caused inverse effects on MYC expression. IL-1β stimulated autophagy flux, causing degradation of p62 and accumulation of MYC. Inhibition of the IL-1R signal transducer kinase IRAK4 in vivo or inhibition of MYC in vivo as well as in human kidney organoids in vitro abrogated fibrosis and reduced tubular injury.Conclusions Our findings define a connection between IL-1β and metabolic switch in fibrosis initiation and progression and highlight IL-1β and MYC as potential therapeutic targets in tubulointerstitial diseases.
引用
- Lemos DR, McMurdo M, Karaca G, et al. Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis. J Am Soc Nephrol. 2018. PMID: 29739813. doi:10.1681/ASN.2017121283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。